Rani Therapeutics Holdings, Inc.
RANIReported to SECin USCIK 0001856725Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 15. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Imran TalatChief Executive Officer | Administrative | $6,0197,928 shares | Sep 29, 2026 | Imran TalatChief Executive Officer | $6,019 | Administrative | 7,928 | Sep 29, 2026 |
| Javadi AlirezaChief Technical Officer | Administrative | $235309 shares | Sep 29, 2026 | Javadi AlirezaChief Technical Officer | $235 | Administrative | 309 | Sep 29, 2026 |
| Gilson Michelle— | Award | nothing paid247,200 shares | Aug 4, 2026 | Gilson Michelle | nothing paid | Award | 247,200 | Aug 4, 2026 |
| IMRAN MIR A— | Open-market buy | $24,84036,000 shares | Jul 23, 2026 | IMRAN MIR A | $24,840 | Open-market buy | 36,000 | Jul 23, 2026 |
| Javadi AlirezaChief Technical Officer | Administrative | $229309 shares | Jul 21, 2026 | Javadi AlirezaChief Technical Officer | $229 | Administrative | 309 | Jul 21, 2026 |